Gainers
- ChemoCentryx CCXI stock increased by 70.43% to $33.41 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 74.6 million shares, making up 3896.18% of its average full-day volume over the last 100 days. The company's market cap stands at $2.3 billion.
- Reshape Lifesciences RSLS stock moved upwards by 27.52% to $3.16. Trading volume for Reshape Lifesciences's stock is 26.4 million as of 12:30 EST. This is 815.46% of its average full-day volume over the last 100 days. The company's market cap stands at $11.0 million.
- Voyager Therapeutics VYGR shares rose 21.35% to $4.66. Trading volume for this security as of 12:30 EST is 24.7 million, which is 674.48% of its average full-day volume over the last 100 days. The company's market cap stands at $176.7 million.
- ORIC Pharmaceuticals ORIC shares rose 15.98% to $14.24. As of 12:30 EST, this security is trading at a volume of 1.1 million shares, making up 472.5% of its average full-day volume over the last 100 days. The company's market cap stands at $559.9 million.
- Endo International ENDP stock increased by 9.79% to $4.0. Trading volume for Endo International's stock is 3.2 million as of 12:30 EST. This is 28.11% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $933.2 million.
- Lantern Pharma LTRN stock increased by 9.07% to $11.18. The market value of their outstanding shares is at $125.0 million.
Losers
- Allogene Therapeutics ALLO stock fell 44.92% to $13.43 during Friday's regular session. The current volume of 16.1 million shares is 2290.18% of Allogene Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $1.9 billion.
- Agile Therapeutics AGRX shares declined by 29.96% to $0.66. As of 12:30 EST, this security is trading at a volume of 10.9 million shares, making up 1667.07% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $61.3 million.
- Cellectis CLLS stock decreased by 22.2% to $9.35. Cellectis's stock is trading at a volume of 1.4 million shares as of 12:30 EST. This is 905.66% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $425.1 million.
- Caribou Biosciences CRBU stock declined by 13.94% to $19.45. The company's market cap stands at $1.1 billion.
- Intellia Therapeutics NTLA stock declined by 10.66% to $120.42. Trading volume for this security as of 12:30 EST is 1.4 million, which is 142.86% of its average full-day volume over the last 100 days. The company's market cap stands at $8.8 billion.
- Editas Medicine EDIT shares declined by 10.32% to $35.01. As of 12:30 EST, this security is trading at a volume of 2.1 million shares, making up 124.53% of its average full-day volume over the last 100 days. The company's market cap stands at $2.3 billion.
See Also: www.benzinga.com/money/best-healthcare-stocks/
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in